Cumulative exposure to premenopausal obesity and risk of postmenopausal cancer: A population-based study in Icelandic women.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 25 07 2019
accepted: 12 11 2019
pubmed: 23 11 2019
medline: 12 3 2021
entrez: 23 11 2019
Statut: ppublish

Résumé

Obesity, often assessed at one point in time, is an established risk factor of several types of cancer, however, associations with cumulative exposure to obesity across the life course are not well understood. We investigated the relationship between combined measures of duration and intensity of premenopausal overweight and obesity and the incidence of postmenopausal breast, endometrial, and colorectal cancers in Icelandic women. Body mass index (BMI) trajectories between ages 20 and 50 of 88,809 women from the Cancer Detection Clinic Cohort were predicted using growth curve models. Indicators of overweight and obesity duration and intensity were computed and their association with risk of postmenopausal breast, endometrial, and colorectal cancers was examined using multivariate Cox models for subjects followed-up beyond the age of 50 (n = 67,488). During a mean follow-up of 17 years, incident events of 3,016 postmenopausal breast, 410 endometrial and 987 colorectal cancers were ascertained. Each 0.1 kg/m

Identifiants

pubmed: 31755107
doi: 10.1002/ijc.32805
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-802

Informations de copyright

© 2019 International Agency for Research on Cancer (IARC/WHO); licensed by UICC.

Références

Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-67.
WHO. World Health Organization (WHO), Global Health Observatory (GHO): Data Repository, 3.4 Noncommunicable diseases and mental health-Noncommunicable disease-Risk factors-Overweight/Obesity. Geneva: WHO, 2018.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med 2016;375:794-8.
Caesar R, Tremaroli V, Kovatcheva-Datchary P, et al. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR Signaling. Cell Metab 2015;22:658-68.
Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 2015;16:36-46.
Arnold M, Freisling H, Stolzenberg-Solomon R, et al. Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol 2016;31:893-904.
Arnold M, Jiang LH, Stefanick ML, et al. Duration of adulthood overweight, obesity, and cancer risk in the Women's Health Initiative: a longitudinal Study from the United States. PLoS Med 2016;13:e1002081.
Song MY, Willett WC, Hu FB, et al. Trajectory of body shape across the lifespan and cancer risk. Int J Cancer 2016;138:2383-95.
Tryggvadottir L, Tulinius H, Eyfjord JE, et al. Breastfeeding and reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol 2001;154:37-42.
Tryggvadottir L, Tulinius H, Eyfjord JE, et al. Breast cancer risk factors and age at diagnosis: An Icelandic cohort study. Int J Cancer 2002;98:604-8.
Sigurdardottir LG, Jonasson JG, Stefansdottir S, et al. Data quality at the Icelandic cancer registry: comparability, validity, timeliness and completeness. Acta Oncol 2012;51:880-9.
Vidarsdottir H, Gunnarsdottir HK, Olafsdottir EJ, et al. Cancer risk by education in Iceland-a census-based cohort study. Acta Oncol 2008;47:385-90.
Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med 1997;16:2349-80.
Pasquali R, Pelusi C, Genghini S, et al. Obesity and reproductive disorders in women. Hum Reprod Update 2003;9:359-72.
Schmandt RE, Iglesias DA, Co NN, et al. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 2011;205:518-25.
Boon WC, Chow JD, Simpson ER. The multiple roles of estrogens and the enzyme aromatase. Prog Brain Res 2010;181:209-32.
Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab 2011;22:145-52.
Park SL, Goodman MT, Zhang ZF, et al. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J Cancer 2010;126:490-9.
Hidayat K, Yang CM, Shi BM. Body fatness at a young age, body fatness gain and risk of breast cancer: systematic review and meta-analysis of cohort studies. Obes Rev 2018;19:254-68.
Fang XX, Wei JY, He XY, et al. Quantitative association between body mass index and the risk of cancer: a global meta-analysis of prospective cohort studies. Int J Cancer 2018;143:1595-603.
Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. Br Med J 2017;356:j477.
Ross R, Aru J, Freeman J, et al. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002;282:E657-63.
Murphy N, Strickler HD, Stanczyk FZ, et al. A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal Women. J Natl Cancer Inst 2015;107:djv210.
Dagan SS, Segev S, Novikov I, et al. Waist circumference vs body mass index in association with cardiorespiratory fitness in healthy men and women: a cross sectional analysis of 403 subjects. Nutr J 2013;12:12.
Bener A, Yousafzai MT, Darwish S, et al. Obesity index that better predict metabolic syndrome: body mass index, waist circumference, waist hip ratio, or waist height ratio. J Obes 2013;2013:269038.
Brown P. Waist circumference in primary care. Prim Care Diabetes 2009;3:259-61.
Seidell JC. Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clin Nutr 2010;64:35-41.
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008;32(Suppl 3):S56-9.
Spencer EA, Appleby PN, Davey GK, et al. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561-5.
Skeie G, Mode N, Henningsen M, et al. Validity of self-reported body mass index among middle-aged participants in the Norwegian Women and cancer study. Clin Epidemiol 2015;7:313-23.
Harris TB, Launer LJ, Eiriksdottir G, et al. Age, gene/environment susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007;165:1076-87.
Stolk L, Perry JRB, Chasman DI, et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet 2012;44:260-U55.
Renehan AG, Flood A, Adams KF, et al. Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP cohort. Am J Epidemiol 2012;176:1130-40.

Auteurs

Hwayoung Noh (H)

Nutritional Methodology and Biostatistics Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Hadrien Charvat (H)

Section of Cancer Surveillance, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Heinz Freisling (H)

Nutritional Methodology and Biostatistics Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Guðríður H Ólafsdóttir (GH)

Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.

Elínborg J Ólafsdóttir (EJ)

Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.

Laufey Tryggvadóttir (L)

Icelandic Cancer Registry, Icelandic Cancer Society, Reykjavik, Iceland.
Faculty of Medicine, Laeknagardur, University of Iceland, Reykjavik, Iceland.

Melina Arnold (M)

Section of Cancer Surveillance, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Isabelle Soerjomataram (I)

Section of Cancer Surveillance, International Agency for Research on Cancer (IARC-WHO), Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH